Schedule 13G ownership disclosure

Principia Biopharma Inc.

Security class unavailable · CUSIP: 74257L108

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,059,146
Percent of class
8.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-006335
Form type
SC 13G
Filer
Principia Biopharma Inc.
CIK
CIK 1510487
Filed
Feb 12, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub